{
    "code": "56025524",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56025524",
    "time": "2020-02-26 07:24:56",
    "許可證字號": "衛部醫器輸字第025524號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD4062",
    "有效日期": "112\/10\/04",
    "發證日期": "102\/10\/04",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05602552401",
    "中文品名": "“奧索” 0.8%紅血球試劑",
    "英文品名": "“Ortho” 0.8% Surgiscreen",
    "效能": "本產品係搭配Ortho BioVue系統使用，用於檢測或辨識無法預期的特異血型抗體。",
    "醫器規格": "719102 (3vial*10ml\/pack)\r\n以下空白\r\n新增可搭配儀器及需要但未提供之材料。\r\n仿單標籤變更：詳如中文仿單核定本。(原102年10月29日仿單標籤核定本正本收回作廢)。以下空白",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器次類別一": "B9175自動血液分類及抗體試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "620118D857  台灣大昌華嘉股份有限公司",
    "申請商地址": "台北市內湖區堤頂大道二段407巷20弄1、3、5、7號10樓及22、24、26號10樓及22號10樓之1",
    "主製造廠": {
        "製造廠名稱": "FUS0139200  ORTHO-CLINICAL DIAGNOSTICS, INC.",
        "製造廠廠址": "1001 U.S. HIGHWAY 202, RARITAN, NEW JERSEY 08869 U.S.A.",
        "製造廠公司地址": "",
        "製造廠國別": "UNITED STATES",
        "製程": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "56025524-107-10-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025524&Seq=002&Type=9"
        },
        {
            "title": "56025524-107-10-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025524&Seq=002&Type=8"
        }
    ]
}